AC
Armistice Capital’s Catalyst Pharmaceutical CPRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-10,200,000
| Closed | -$71.5K | – | 205 |
|
2022
Q2 | $71.5K | Buy |
10,200,000
+1,828,000
| +22% | +$12.8K | 1.25% | 18 |
|
2022
Q1 | $69.4M | Sell |
8,372,000
-1,200,000
| -13% | -$9.95M | 1.34% | 12 |
|
2021
Q4 | $64.8M | Sell |
9,572,000
-428,000
| -4% | -$2.9M | 1.06% | 21 |
|
2021
Q3 | $53M | Hold |
10,000,000
| – | – | 0.9% | 22 |
|
2021
Q2 | $57.5M | Hold |
10,000,000
| – | – | 1.03% | 22 |
|
2021
Q1 | $46.1M | Hold |
10,000,000
| – | – | 1.06% | 28 |
|
2020
Q4 | $33.4M | Hold |
10,000,000
| – | – | 1.14% | 24 |
|
2020
Q3 | $29.7M | Buy |
10,000,000
+3,800,000
| +61% | +$11.3M | 1.08% | 32 |
|
2020
Q2 | $28.6M | Buy |
6,200,000
+800,000
| +15% | +$3.7M | 1.26% | 26 |
|
2020
Q1 | $20.8M | Buy |
5,400,000
+300,000
| +6% | +$1.16M | 1.29% | 31 |
|
2019
Q4 | $19.1M | Buy |
+5,100,000
| New | +$19.1M | 1.1% | 28 |
|
2019
Q3 | – | Sell |
-5,000,000
| Closed | -$19.2M | – | 64 |
|
2019
Q2 | $19.2M | Buy |
5,000,000
+3,480,000
| +229% | +$13.4M | 1.21% | 25 |
|
2019
Q1 | $7.75M | Buy |
1,520,000
+140,000
| +10% | +$714K | 0.42% | 39 |
|
2018
Q4 | $2.65M | Sell |
1,380,000
-292,000
| -17% | -$561K | 0.2% | 51 |
|
2018
Q3 | $6.32M | Sell |
1,672,000
-28,000
| -2% | -$106K | 0.38% | 49 |
|
2018
Q2 | $5.3M | Buy |
+1,700,000
| New | +$5.3M | 0.35% | 53 |
|